{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:23:51Z","timestamp":1790461431566,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1093\/toxsci\/kfj169","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T04:38:14Z","timestamp":1143607094000},"page":"610-619","source":"Crossref","is-referenced-by-count":90,"title":["Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts"],"prefix":"10.1093","volume":"91","author":[{"given":"Rebecca L.","family":"Sheets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Scott","family":"Manetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Nason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charla","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Pui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Nabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip L.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,3,28]]},"reference":[{"key":"key\n\t\t\t\t20171013185638_BIB1","doi-asserted-by":"crossref","unstructured":"Barouch, D., Truitt, D. M., and Letvin, N. L. (2004). Expression kinetics of the interleukin-2\/immunoglobulin (IL-2\/Ig) plasmid cytokine adjuvant. Vaccine22,3092\u20133097.","DOI":"10.1016\/j.vaccine.2004.01.065"},{"key":"key\n\t\t\t\t20171013185638_BIB2","doi-asserted-by":"crossref","unstructured":"Barouch, D., Yang, Z.-Y., Kong, W.-P., Korioth-Schmitz, B., Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Miura, A., Mascola, J. R., et al. (2005). An HTLV-1 regulatory element enhances the immunogenicity of HIV-1 DNA vaccines in mice and nonhuman primates. J. Virol.79,9694\u20139701.","DOI":"10.1128\/JVI.79.14.8828-8834.2005"},{"key":"key\n\t\t\t\t20171013185638_BIB3","unstructured":"CBER. (1996). Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Disease Indications. CBER."},{"key":"key\n\t\t\t\t20171013185638_BIB4","unstructured":"CBER. (2005). Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications. CBER."},{"key":"key\n\t\t\t\t20171013185638_BIB5","doi-asserted-by":"crossref","unstructured":"Chakrabarti, B. K., Kong, W.-P., Wu, B.-Y., Yang, Z.-Y., Friborg, J., Ling, X., King, S. R., Montifiori, D. C., and Nabel, G. J. (2002). Modifications of the human immunodeficiency virus envelope glycoprotein enhances immunogenicity for genetic immunization. J. Virol.76,5357\u20135368.","DOI":"10.1128\/JVI.76.11.5357-5368.2002"},{"key":"key\n\t\t\t\t20171013185638_BIB6","doi-asserted-by":"crossref","unstructured":"Epstein, J. E., Gorak, E. J., Charoenvit, Y., Wang, R., Freydberg, N., Osinowo, O., Richie, T. L., Stoltz, E. L., Trespalacios, F., and Nerges, J. (2002). Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular\/intradermal routes. Hum. Gene Ther.13,1551\u20131560.","DOI":"10.1089\/10430340260201644"},{"key":"key\n\t\t\t\t20171013185638_BIB7","doi-asserted-by":"crossref","unstructured":"Epstein, J. E., Charoenvit, Y., Kester, K. E., Wang, R., Newcomer, R., Fitzpatrick, S., Richie, T. L., Tornieporth, N., Heppner, D. G., and Ockenhouse, C., (2004). Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S\/AS02A. Vaccine22,1592\u20131603.","DOI":"10.1016\/j.vaccine.2004.01.031"},{"key":"key\n\t\t\t\t20171013185638_BIB8","doi-asserted-by":"crossref","unstructured":"Martin J. E., Enama M. E., Koup R. A., Bailer R. T., Moodie Z., Roederer M., Nabel G. J., and Graham B. S. (2005) VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP). J. Allergy. Clin. Immunol.115, 892.","DOI":"10.1016\/j.jaci.2005.01.050"},{"key":"key\n\t\t\t\t20171013185638_BIB9","doi-asserted-by":"crossref","unstructured":"Hartikka, J., Sawdey, M., Cornefert-Jensen, F., Margalith, M., Barnhart, K., Nolasco, M., Vahlsing, H. L., Meek, J., Marquet, M., and Hobart, P. (1996). An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther.7,1205\u20131217.","DOI":"10.1089\/hum.1996.7.10-1205"},{"key":"key\n\t\t\t\t20171013185638_BIB10","doi-asserted-by":"crossref","unstructured":"Huang, Y., Kong, W.-P., and Nabel, G. J. (2001). Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J. Virol.75,4947\u20134951.","DOI":"10.1128\/JVI.75.10.4947-4951.2001"},{"key":"key\n\t\t\t\t20171013185638_BIB11","doi-asserted-by":"crossref","unstructured":"Kong, W.-P., Huang, Y., Yang, Z.-Y., Chakrabarti, B. K., Moodie, Z., and Nabel, G. J. (2003). Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines. J. Virol.77,12764\u201312772.","DOI":"10.1128\/JVI.77.23.12764-12772.2003"},{"key":"key\n\t\t\t\t20171013185638_BIB19","doi-asserted-by":"crossref","unstructured":"Sheets, R. L., Stein, J., Manetz, T. S., Andrews, C., Bailer, R., Rathmann, J., and Gomez, P. L. (2006). Toxicological Safety Evaluation of DNA Plasmid Vaccines Against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus is Similar Despite Differing Plasmid Backbones or Gene Inserts.","DOI":"10.1093\/toxsci\/kfj170"},{"key":"key\n\t\t\t\t20171013185638_BIB12","doi-asserted-by":"crossref","unstructured":"Sullivan, N. J., Peterson, M., Yang, Z. Y., Kong, W. P., Duckers, H., Nabel, E., and Nabel, G. J. (2005). Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J. Virol.79,547\u2013553.","DOI":"10.1128\/JVI.79.1.547-553.2005"},{"key":"key\n\t\t\t\t20171013185638_BIB13","doi-asserted-by":"crossref","unstructured":"Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z. Y., and Nabel, G. J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature408,605\u2013609.","DOI":"10.1038\/35046108"},{"key":"key\n\t\t\t\t20171013185638_BIB14","unstructured":"Title 21 Code of Federal Regulations (CFR). Part 58."},{"key":"key\n\t\t\t\t20171013185638_BIB15","doi-asserted-by":"crossref","unstructured":"Ulmer, J. B., Sadoff, J. C., and Liu, M. A. (1996). DNA vaccines. Curr. Opin. Immunol.8,531\u2013536.","DOI":"10.1016\/S0952-7915(96)80042-2"},{"key":"key\n\t\t\t\t20171013185638_BIB16","doi-asserted-by":"crossref","unstructured":"Wang, Z., Troilo, P. J., Wang, X., Griffiths, T. G., Pacchione, S. J., Barnum, A. B., Harper, L. B., Pauley, C. J., Niu, Z., Denisova, L., et al. (2004). Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther.11,711\u2013721.","DOI":"10.1038\/sj.gt.3302213"},{"key":"key\n\t\t\t\t20171013185638_BIB17","doi-asserted-by":"crossref","unstructured":"Xu, L., Sanchez, A., Yang, Z., Zaki, S. R., Nabel, E. G., Nichol, S. T., and Nabel, G.J. (1998). Immunization for Ebola virus infection. Nat. Med.4,37\u201342.","DOI":"10.1038\/nm0198-037"},{"key":"key\n\t\t\t\t20171013185638_BIB18","doi-asserted-by":"crossref","unstructured":"Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., and Nabel, G. J. (2004). A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature428,561\u2013564.","DOI":"10.1038\/nature02463"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/91\/2\/610\/10977044\/kfj169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T17:29:00Z","timestamp":1555522140000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/91\/2\/610\/1656770\/Biodistribution-of-DNA-Plasmid-Vaccines-against"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,28]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,3,28]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfj169","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,6]]},"published":{"date-parts":[[2006,3,28]]}}}